Knock Out Opioid Abuse Initiative Launches New Online Course for Prescribers

MILLBURN, N.J., June 4, 2019 /PRNewswire/ — In response to the opioid epidemic ravaging New Jersey, the Partnership for a Drug-Free New Jersey (PDFNJ) and Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) have turned their focus toward educating prescribers on safe and responsible prescribing.

PDFNJ and Horizon BCBSNJ — through its philanthropic arm, The Horizon Foundation for New Jersey —launched a one-hour continuing medical education webinar, “Do No Harm: Exploring Strategies for Safer Prescribing of Opioids,” on May 31. It is available to all prescribers across the state to strengthen safer prescribing of opioids through education.

“Prescriber education is key to helping stem the tide of the opioid epidemic,” PDFNJ Executive Director Angelo Valente said. “This online course will provide doctors, dentists, nurses and nurse practitioners with the information they need to make the best decisions for their patients. We know this effort will make an impact.”

The course is part of a new two-year Knock Out Opioid Abuse initiative to address the opioid epidemic through community outreach, prescriber education, parent education and a statewide awareness campaign.  The campaign will include a new micro-website that will be an informational and interactive hub on opioids, transit and outdoor advertising, and social media communications.

“Opioid abuse prevention efforts should start right in a clinical setting, whether that setting is a doctor’s office, dental practice, hospital or other health care environment,” said Jonathan R. Pearson, Executive Director of The Horizon Foundation for New Jersey. “That’s why Horizon is working with the Partnership to ensure that all prescribers become accredited in best practices for safe and effective prescribing for pain management.”

The accredited curriculum will be accessible through the website, www.KnockOutOpioidAbuse.DrugFreeNJ.org/NJSafeRx, for an administrative fee of $35. The course satisfies the New Jersey one-hour continuing education requirement concerning prescription opioid drugs, including education on responsible prescribing practices, alternatives to opioids for managing and treating pain, and the risks and signs of opioid abuse, addiction and diversion.

The course is specifically tailored for healthcare professionals including doctors of medicine, nurse practitioners, physician assistants, residents and fellows, medical students, and dentists.

The curriculum includes information from medical, legal and law enforcement perspectives. The course instructors are:

  • Lewis S. Nelson, MD, Professor and Chair, Department of Emergency Medicine, Rutgers NJMS; Chief of Service, Emergency Department, University Hospital
  • Andrew E. Blustein, Partner/Director, Garfunkel Wild, P.C. Attorney at Law
  • Assistant Special Agent in Charge Christopher Jakim, Drug Enforcement Administration – New Jersey Division

Over the past six years, PDFNJ has teamed with the Drug Enforcement Administration – New Jersey Division and the New York/New Jersey High Intensity Drug Trafficking Areas program to coordinate the Do No Harm prescriber education series. The series provides medical professionals information on the need for safer prescribing practices. More than 97 percent of attendees have said they have implemented safer prescribing practices based on the training they have received.

Partnership for a Drug-Free New Jersey: Best known for its statewide substance use prevention advertising campaign, the Partnership for a Drug-Free New Jersey is a private not-for-profit coalition of professionals from the communications, corporate and government communities whose collective mission is to reduce demand for illicit drugs in New Jersey through media communication.  To date, more than $100 million in broadcast time and print space has been donated to the Partnership’s New Jersey campaign, making it the largest public service advertising campaign in New Jersey’s history. Since its inception, the Partnership has garnered 174 advertising and public relations awards from national, regional and statewide media organizations.

About Horizon Blue Cross Blue Shield of New Jersey: Horizon Blue Cross Blue Shield of New Jersey, the state’s oldest and largest health insurer is a tax-paying, not-for-profit health service corporation, providing a wide array of medical, dental, vision and prescription insurance products and services. Horizon BCBSNJ is leading the transformation of health care in New Jersey by working with doctors and hospitals to deliver innovative, patient-centered programs that reward the quality, not quantity, of care patients receive. Learn more at www.HorizonBlue.com. Horizon BCBSNJ is an independent licensee of the Blue Cross and Blue Shield Association serving more than 3.7 million members.

About The Horizon Foundation For New Jersey: The Horizon Foundation for New Jersey is committed to working alongside those who can help us improve our neighbors’ health, inform their health decisions and inspire them to lead healthier, more fulfilling lives. The Foundation’s funding pillars are Caring, Connecting and Creating. Horizon Blue Cross Blue Shield of New Jersey is the sole member of The Horizon Foundation for New Jersey, both of which are independent licensees of the Blue Cross and Blue Shield Association. For more information, please visit www.Horizonblue.com/Foundation

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/knock-out-opioid-abuse-initiative-launches-new-online-course-for-prescribers-300861568.html

SOURCE Partnership for a Drug-Free New Jersey

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

1 hour ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

1 hour ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

1 hour ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

1 hour ago